View source for Neurocan

{{Short description|Protein-coding gene in the species Homo sapiens}}
{{Infobox_gene}}
'''Neurocan core protein''' is a [[protein]] that in humans is encoded by the ''NCAN'' [[gene]].<ref name="pmid1326557">{{cite journal |vauthors=Rauch U, Karthikeyan L, Maurel P, Margolis RU, Margolis RK | title = Cloning and primary structure of neurocan, a developmentally regulated, aggregating chondroitin sulfate proteoglycan of brain | journal = J Biol Chem | volume = 267 | issue = 27 | pages = 19536–47 | date = Oct 1992 | doi = 10.1016/S0021-9258(18)41808-X | pmid = 1326557 | doi-access = free }}</ref><ref name="entrez">{{cite web | title = Entrez Gene: NCAN neurocan| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=1463}}</ref>
'''Neurocan''' is a member of the [[lectican]] / [[chondroitin sulfate proteoglycan]] protein families and consists of neurocan core protein and [[chondroitin sulfate]]. It is thought to be involved in the modulation of [[cell adhesion]] and migration.<ref name="entrez"/>
== Role in bipolar disorder ==
Neurocan is a significant component of the extracellular matrix, and its levels are modulated by a variety of factors, but mice in which the NCAN gene has been knocked out show no easily observable defects in brain development or behavior.<ref>{{cite journal |vauthors=Zhou XH, Brakebusch C, Matthies H, Oohashi T, Hirsch E, Moser M, Krug M, Seidenbecher CI, Boeckers TM, Rauch U, Buettner R, Gundelfinger ED, Fässler R | title = Neurocan is dispensable for brain development | journal = Mol. Cell. Biol. | volume = 21 | issue = 17 | pages = 5970–8 | date = September 2001 | pmid = 11486035 | pmc = 87315 | doi = 10.1128/MCB.21.17.5970-5978.2001 }}</ref>  However, a genome-wide association study published in 2011 identified Neurocan as a susceptibility factor for [[bipolar disorder]].<ref>{{cite journal |vauthors=Cichon S, Mühleisen TW, Degenhardt FA, Mattheisen M, Miró X, Strohmaier J, Steffens M, Meesters C, Herms S, Weingarten M, Priebe L, Haenisch B, Alexander M, Vollmer J, Breuer R, Schmäl C, Tessmann P, Moebus S, Wichmann HE, Schreiber S, Müller-Myhsok B, Lucae S, Jamain S, Leboyer M, Bellivier F, Etain B, Henry C, Kahn JP, Heath S, Hamshere M, O'Donovan MC, Owen MJ, Craddock N, Schwarz M, Vedder H, Kammerer-Ciernioch J, Reif A, Sasse J, Bauer M, Hautzinger M, Wright A, Mitchell PB, Schofield PR, Montgomery GW, Medland SE, Gordon SD, Martin NG, Gustafsson O, Andreassen O, Djurovic S, Sigurdsson E, Steinberg S, Stefansson H, Stefansson K, Kapur-Pojskic L, Oruc L, Rivas F, Mayoral F, Chuchalin A, Babadjanova G, Tiganov AS, Pantelejeva G, Abramova LI, Grigoroiu-Serbanescu M, Diaconu CC, Czerski PM, Hauser J, Zimmer A, Lathrop M, Schulze TG, Wienker TF, Schumacher J, Maier W, Propping P, Rietschel M, Nöthen MM | title = Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder | journal = Am. J. Hum. Genet. | volume = 88 | issue = 3 | pages = 372–81 | date = March 2011 | pmid = 21353194 | pmc = 3059436 | doi = 10.1016/j.ajhg.2011.01.017 }}</ref>  A more comprehensive study published in 2012 confirmed that association.<ref>{{cite journal |vauthors=Miró X, Meier S, Dreisow ML, Frank J, Strohmaier J, Breuer R, Schmäl C, Albayram Ö, Pardo-Olmedilla MT, Mühleisen TW, Degenhardt FA, Mattheisen M, Reinhard I, Bilkei-Gorzo A, Cichon S, Seidenbecher C, Rietschel M, Nöthen MM, Zimmer A | title = Studies in humans and mice implicate neurocan in the etiology of mania | journal = Am J Psychiatry | volume = 169 | issue = 9 | pages = 982–90 | date = September 2012 | pmid = 22952076 | doi = 10.1176/appi.ajp.2012.11101585 | s2cid = 13621844 }}</ref>  The 2012 study examined correlations between NCAN alleles and various symptoms of bipolar disorder, and also examined the behavior of NCAN knockout mice.  In the human subjects, it was found that NCAN genotype was strongly associated with manic symptoms but not with depressive symptoms.  In the mice, the absence of functional Neurocan resulted in a variety of manic-like behaviors, which could be normalized by administering lithium.
==References==
{{reflist}}
==Further reading==
{{refbegin | 2}}
*{{cite journal |vauthors=Rauch U, Grimpe B, Kulbe G, Arnold-Ammer I, Beier DR, Fässler R | title = Structure and chromosomal localization of the mouse neurocan gene. | journal = Genomics | volume = 28 | issue = 3 | pages = 405–10 | year = 1996 | pmid = 7490074 | doi = 10.1006/geno.1995.1168 }}
*{{cite journal |vauthors=Friedlander DR, Milev P, Karthikeyan L, Margolis RK, Margolis RU, Grumet M | title = The neuronal chondroitin sulfate proteoglycan neurocan binds to the neural cell adhesion molecules Ng-CAM/L1/NILE and N-CAM, and inhibits neuronal adhesion and neurite outgrowth. | journal = J. Cell Biol. | volume = 125 | issue = 3 | pages = 669–80 | year = 1994 | pmid = 7513709 | pmc = 2119998 | doi = 10.1083/jcb.125.3.669 }}
*{{cite journal |vauthors=Milev P, Maurel P, Häring M, Margolis RK, Margolis RU | title = TAG-1/axonin-1 is a high-affinity ligand of neurocan, phosphacan/protein-tyrosine phosphatase-zeta/beta, and N-CAM. | journal = J. Biol. Chem. | volume = 271 | issue = 26 | pages = 15716–23 | year = 1996 | pmid = 8663515 | doi = 10.1074/jbc.271.26.15716 | doi-access = free }}
*{{cite journal |vauthors=Retzler C, Göhring W, Rauch U | title = Analysis of neurocan structures interacting with the neural cell adhesion molecule N-CAM. | journal = J. Biol. Chem. | volume = 271 | issue = 44 | pages = 27304–10 | year = 1996 | pmid = 8910306 | doi = 10.1074/jbc.271.44.27304 | doi-access = free }}
*{{cite journal |vauthors=Rauch U, Clement A, Retzler C, Fröhlich L, Fässler R, Göhring W, Faissner A | title = Mapping of a defined neurocan binding site to distinct domains of tenascin-C. | journal = J. Biol. Chem. | volume = 272 | issue = 43 | pages = 26905–12 | year = 1997 | pmid = 9341124 | doi = 10.1074/jbc.272.43.26905 | doi-access = free }}
*{{cite journal |vauthors=Milev P, Chiba A, Häring M, Rauvala H, Schachner M, Ranscht B, Margolis RK, Margolis RU | title = High affinity binding and overlapping localization of neurocan and phosphacan/protein-tyrosine phosphatase-zeta/beta with tenascin-R, amphoterin, and the heparin-binding growth-associated molecule. | journal = J. Biol. Chem. | volume = 273 | issue = 12 | pages = 6998–7005 | year = 1998 | pmid = 9507007 | doi = 10.1074/jbc.273.12.6998 | doi-access = free }}
*{{cite journal |vauthors=Prange CK, Pennacchio LA, Lieuallen K, Fan W, Lennon GG | title = Characterization of the human neurocan gene, CSPG3. | journal = Gene | volume = 221 | issue = 2 | pages = 199–205 | year = 1998 | pmid = 9795216 | doi = 10.1016/S0378-1119(98)00455-7 | url = https://zenodo.org/record/1260053 }}
*{{cite journal |vauthors=Oleszewski M, Gutwein P, von der Lieth W, Rauch U, Altevogt P | title = Characterization of the L1-neurocan-binding site. Implications for L1-L1 homophilic binding. | journal = J. Biol. Chem. | volume = 275 | issue = 44 | pages = 34478–85 | year = 2000 | pmid = 10934197 | doi = 10.1074/jbc.M004147200 | doi-access = free }}
*{{cite journal |vauthors=Hartley JL, Temple GF, Brasch MA | title = DNA cloning using in vitro site-specific recombination. | journal = Genome Res. | volume = 10 | issue = 11 | pages = 1788–95 | year = 2001 | pmid = 11076863 | pmc = 310948 | doi = 10.1101/gr.143000 }}
*{{cite journal |vauthors=Brandenberger R, Wei H, Zhang S, Lei S, Murage J, Fisk GJ, Li Y, Xu C, Fang R, Guegler K, Rao MS, Mandalam R, Lebkowski J, Stanton LW | title = Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation. | journal = Nat. Biotechnol. | volume = 22 | issue = 6 | pages = 707–16 | year = 2005 | pmid = 15146197 | doi = 10.1038/nbt971 | s2cid = 27764390 }}
{{refend}}
{{Lectins}}
{{Proteoglycans}}
[[Category:C-type lectins]]
[[Category:Lecticans]]
[[Category:Extracellular matrix proteins]]
{{gene-19-stub}}